12
Views
9
CrossRef citations to date
0
Altmetric
Research Article

The N-Methyl-D-Aspartate Receptor Complex

, , , , &
Pages 195-203 | Published online: 26 Sep 2008

References

  • Anis N. A., Berry S. C., Burton N. R., Lodge D. The dissociative anesthetics, ketamine and phencyclidine selectively reduce excitation of central mammalian neurones by N-methyl-D-aspartate. Br. J. Pharmacol. 1983; 79: 565–575
  • Loo P., Braunwalder A., Lehmann J., Williams M. Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. Eur. J. Pharmacol. 1986; 123: 467–468
  • Loo P. A., Braunwalder A. F., Lehmann J., Williams M., Sills M. A. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex. Mol. Pharmacol. 1987, submitted
  • Fagg G. E., Baud J. Activation of N-methyl-D-aspartate (NMDA) receptors unmasks 3H-TCP binding sites in brain membranes: further evidence that phencyclidine blocks the open NMDA receptor channel. Soc. Neurosci. Abstr. 1986; 12: 958
  • Collingridge G. L. Long term potentiation in the hippocampus: mechanisms of initiation and modulation by neurotransmitters. Trends Pharmacol. Sci. 1985; 6: 407–411
  • Lehmann J., Loo P., McPherson S., French-Mullen J. M.H., Steel D., Braunwalder A., Williams M., Wood P. L. Excitatory Amino Acid Transmission, T. P. Hicks, D. Lodge, H. McLennan. Liss, New York, N.Y. 1987; 91–98
  • Lehmann J., Schneider J., Williams M. Excitatory amino acid receptors and mammalian CNS function. Ann. Rep. Med. Chem. 1987; 22, in press
  • Williams M. Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics. Prog. Neuropsychopharmacol. Biol. Psychiatr. 1984; 8: 209–247
  • Nowak L., Bregestovski P, Ascher P, Herbert A., Prochaintz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature (London) 1984; 307: 462–465
  • Wong E. F., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK 801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 7104–7108
  • Clineschmidt B. V., Williams M., Witoslawski J. J., Bunting P. R., Risley E. A., Totaro J. A. Restoration of shock supressed behavior by treatment with (+)- 5-methyl-10,11-dihydro-5H-dibenzo[a,b]-cyclohepten-5,10-amine (MK 801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug. Develop. Res. 1982; 2: 147–163
  • Murphy D. E., Schneider J., Boehm C., Lehmann J., Williams M. Binding of [3H](3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) to rat brain membranes: a selective high affinity ligand for N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 1987; 240, in press
  • Vignon J., Chicheportiche R., Chicheportiche M., Kamenk J.-M., Geneste P., Lazdunsky M. [3H]TCP: a new tool with high affinity for the PCP receptor in the rat brain. Brain Res. 1983; 280: 194–197
  • Loo P. A., Braunwalder A. F., Williams M., Sills M. A. The novel anticonvulsant, MK 801 selectively interacts with central phencyclidine recognition sites. Eur. J. Pharmacol. 1987, in press
  • Haring R., Kloog Y., Harshak-Felixbrodt N.-A., Sokolovsky M. Mutiple mode of binding of phencyclidines: high affinity association between phencyclidine receptors in rat brain and a monovalent-ion sensitive polypeptide. Biochem. Biophys. Res. Comm. 1987; 142: 501–510
  • Squires R. F., Williams M. Anxioselective anxiolytics. J.Med. Chem. 1983; 26: 619–628
  • Maragos W., Chu D. C.M., Greenamyre J. T., Penney J. B., Young A. B. High correlation between the localization of [3H]TCP binding and NMDA receptors. Eur. J. Pharmacol. 1986; 123: 173–174
  • Jarvis M. F., Murphy D. E., Williams M. Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites. Eur. J. Pharmacol. 1987, submitted

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.